Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2023 Filed May 2, 2023 20:04 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock | 3,571 | $16.66 | $59,492.86 |
DisclosureSEC source: 0001069530-23-000019 · certent-form4.xml · nonDerivative · entry 2 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2023 Filed May 2, 2023 20:04 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock | 2,142 | $16.66 | $35,685.72 |
DisclosureSEC source: 0001069530-23-000019 · certent-form4.xml · nonDerivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:12 UTC |
O DONNELL MICHAEL JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,571 | $16.66 Strike: $16.66 | $59,492.86 |
DisclosureSEC source: 0001069530-23-000013 · certent-form4.xml · derivative · entry 6 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,571 shares Expires 2023-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:12 UTC |
O DONNELL MICHAEL JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,571 | $19.60 Strike: $19.60 | $69,991.60 |
DisclosureSEC source: 0001069530-23-000013 · certent-form4.xml · derivative · entry 5 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,571 shares Expires 2023-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:12 UTC |
O DONNELL MICHAEL JDirector
|
Tax withholdingCommon Stock | 2,778 | $25.20 | $70,005.60 |
DisclosureSEC source: 0001069530-23-000013 · certent-form4.xml · nonDerivative · entry 4 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,873 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:12 UTC |
O DONNELL MICHAEL JDirector
|
Tax withholdingCommon Stock | 2,361 | $25.20 | $59,497.20 |
DisclosureSEC source: 0001069530-23-000013 · certent-form4.xml · nonDerivative · entry 3 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,651 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:12 UTC |
O DONNELL MICHAEL JDirector
|
Exercise / conversionCommon Stock | 3,571 | $19.60 | $69,991.60 |
DisclosureSEC source: 0001069530-23-000013 · certent-form4.xml · nonDerivative · entry 2 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:12 UTC |
O DONNELL MICHAEL JDirector
|
Exercise / conversionCommon Stock | 3,571 | $16.66 | $59,492.86 |
DisclosureSEC source: 0001069530-23-000013 · certent-form4.xml · nonDerivative · entry 1 O DONNELL MICHAEL J · CIK 0001245266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:07 UTC |
Barry RichardDirector
|
PurchaseCommon Stock | 77,276 | $25.76 | $1,990,629.76 |
DisclosureSEC source: 0001069530-23-000011 · certent-form4.xml · nonDerivative · entry 2 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 275,000 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.51 to $26.20 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:07 UTC |
Barry RichardDirector
|
PurchaseCommon Stock | 11,565 | $26.13 | $302,193.45 |
DisclosureSEC source: 0001069530-23-000011 · certent-form4.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 197,724 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.51 to $26.20 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 20:54 UTC |
Cook Robert ChristopherSVP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $36.76 Strike: $36.76 | $3,676,000.00 |
DisclosureSEC source: 0001069530-22-000054 · certent-form4.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-10-28 F1 · derivative.exercise_date: Stock options vest over a four (4) year period at a rate of 1/48th per month. Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 22:01 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock · Derivative | 9,376 | $0.95 Strike: $0.95 | $8,907.20 |
DisclosureSEC source: 0001069530-22-000049 · certent-form4.xml · derivative · entry 3 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,624 Underlying: Common Stock · 9,376 shares Expires 2028-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 22:01 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 9,376 | $0.95 | $8,907.20 |
DisclosureSEC source: 0001069530-22-000049 · certent-form4.xml · nonDerivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction represents exercise of stock options for cash. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:00 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock · Derivative | 2,802 | $23.59 Strike: $23.59 | $66,099.18 |
DisclosureSEC source: 0001069530-22-000043 · certent-form4.xml · derivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,802 shares Expires 2022-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:00 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock | 2,802 | $23.59 | $66,099.18 |
DisclosureSEC source: 0001069530-22-000043 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2022 Filed Aug 24, 2022 20:02 UTC |
Kupiec James WilliamChief Clinical Dev. Officer
|
PurchaseCommon Stock | 2,500 | $24.44 | $61,100.00 |
DisclosureSEC source: 0001069530-22-000039 · certent-form4.xml · nonDerivative · entry 1 Kupiec James William · CIK 0001839551 · Chief Clinical Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:20 UTC |
Barry RichardDirector
|
PurchaseCommon Stock | 36,159 | $23.79 | $860,222.61 |
DisclosureSEC source: 0001069530-22-000041 · certent-form4.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 186,159 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.52 to $23.92 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:28 UTC |
Schoen EricChief Financial Officer
|
PurchaseCommon Stock | 2,500 | $19.95 | $49,875.00 |
DisclosureSEC source: 0001069530-22-000037 · certent-form4.xml · nonDerivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 F1 · shares: Represents open market purchase of common stock for cash Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:24 UTC |
ROBERTSON SANFORDDirector
|
PurchaseCommon Stock | 100,000 | $20.69 | $2,069,000.00 |
DisclosureSEC source: 0001069530-22-000035 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024,765 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $19.79 to $21.31 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote. Read SEC document |
| June 07, 2022 Filed Feb 7, 2023 22:02 UTC |
BARBIER REMIDirector · President and CEO
|
OtherCommon Stock | 57,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001069530-23-000004 · certent-form5.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710,574 F1 · shares: Represents restricted stock awards which expired in 2022 as associated performance criteria were not attained. These shares of restricted stock were returned to the 2008 Equity Incentive Plan, which expired December 2017, and thus were retired. No shares of common stock were sold or otherwise monetized in this transaction. Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 22:24 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 65,368 | $23.38 Strike: $23.38 | $1,528,303.84 |
DisclosureSEC source: 0001069530-22-000029 · certent-form4.xml · derivative · entry 4 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,368 shares Expires 2022-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 22:24 UTC |
BARBIER REMIDirector · President and CEO
|
Tax withholdingCommon Stock | 54,720 | $27.93 | $1,528,329.60 |
DisclosureSEC source: 0001069530-22-000029 · certent-form4.xml · nonDerivative · entry 2 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 767,717 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 22:24 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock | 65,368 | $23.38 | $1,528,303.84 |
DisclosureSEC source: 0001069530-22-000029 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:20 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock · Derivative | 24,513 | $23.38 Strike: $23.38 | $573,113.94 |
DisclosureSEC source: 0001069530-22-000027 · certent-form4.xml · derivative · entry 7 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,513 shares Expires 2022-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:20 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock · Derivative | 3,501 | $23.38 Strike: $23.38 | $81,853.38 |
DisclosureSEC source: 0001069530-22-000027 · certent-form4.xml · derivative · entry 6 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,501 shares Expires 2022-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:20 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 21,498 | $26.66 | $573,136.68 |
DisclosureSEC source: 0001069530-22-000027 · certent-form4.xml · nonDerivative · entry 4 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,534 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:20 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 3,071 | $26.66 | $81,872.86 |
DisclosureSEC source: 0001069530-22-000027 · certent-form4.xml · nonDerivative · entry 3 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,032 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:20 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 24,513 | $23.38 | $573,113.94 |
DisclosureSEC source: 0001069530-22-000027 · certent-form4.xml · nonDerivative · entry 2 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:20 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
Exercise / conversionCommon Stock | 3,501 | $23.38 | $81,853.38 |
DisclosureSEC source: 0001069530-22-000027 · certent-form4.xml · nonDerivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2022 Filed Apr 25, 2022 22:29 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 4,669 | $16.31 Strike: $16.31 | $76,151.39 |
DisclosureSEC source: 0001069530-22-000019 · certent-form4.xml · derivative · entry 5 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Disclosed balance after: 0 Underlying: Common Stock · 4,669 shares Expires 2022-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2022 Filed Apr 25, 2022 22:29 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 44,791 | $0.10 Strike: $0.95 | $4,255.15 |
DisclosureSEC source: 0001069530-22-000019 · certent-form4.xml · derivative · entry 4 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Disclosed balance after: 5,209 Underlying: Common Stock · 44,791 shares Expires 2028-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2022 Filed Apr 25, 2022 22:29 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock | 4,669 | $16.31 | $76,151.39 |
DisclosureSEC source: 0001069530-22-000019 · certent-form4.xml · nonDerivative · entry 2 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Disclosed balance after: 376,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction represents exercise of stock options for cash. Read SEC document |
| April 25, 2022 Filed Apr 25, 2022 22:29 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock | 44,791 | $0.95 | $42,551.45 |
DisclosureSEC source: 0001069530-22-000019 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Disclosed balance after: 371,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction represents exercise of stock options for cash. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 23:20 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock · Derivative | 2,801 | $23.59 Strike: $23.59 | $66,075.59 |
DisclosureSEC source: 0001069530-22-000017 · certent-form4.xml · derivative · entry 5 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,801 shares Expires 2022-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 23:20 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock · Derivative | 4,669 | $20.30 Strike: $20.30 | $94,780.70 |
DisclosureSEC source: 0001069530-22-000017 · certent-form4.xml · derivative · entry 4 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,669 shares Expires 2022-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 23:20 UTC |
GUSSIN ROBERT ZDirector
|
Tax withholdingCommon Stock | 4,024 | $39.98 | $160,879.52 |
DisclosureSEC source: 0001069530-22-000017 · certent-form4.xml · nonDerivative · entry 3 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,410 F1 · shares: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 23:20 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock | 2,801 | $23.59 | $66,075.59 |
DisclosureSEC source: 0001069530-22-000017 · certent-form4.xml · nonDerivative · entry 2 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2022 Filed Mar 29, 2022 23:20 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock | 4,669 | $20.30 | $94,780.70 |
DisclosureSEC source: 0001069530-22-000017 · certent-form4.xml · nonDerivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 21:57 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock · Derivative | 4,670 | $20.30 Strike: $20.30 | $94,801.00 |
DisclosureSEC source: 0001069530-22-000015 · certent-form4.xml · derivative · entry 2 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,670 shares Expires 2022-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 21:57 UTC |
ROBERTSON SANFORDDirector
|
Exercise / conversionCommon Stock | 4,670 | $20.30 | $94,801.00 |
DisclosureSEC source: 0001069530-22-000015 · certent-form4.xml · nonDerivative · entry 1 ROBERTSON SANFORD · CIK 0001250105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Jan 3, 2023 21:16 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
GiftCommon Stock | 990 | $0.00 | $0.00 |
DisclosureSEC source: 0001069530-23-000002 · certent-form5.xml · nonDerivative · entry 2 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,910 F1 · price: Bona Fide Gift Read SEC document |
| January 31, 2022 Filed Jan 3, 2023 21:16 UTC |
FRIEDMANN NADAVDirector · Chief Medical Officer
|
GiftCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001069530-23-000002 · certent-form5.xml · nonDerivative · entry 1 FRIEDMANN NADAV · CIK 0001245267 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,900 F1 · price: Bona Fide Gift Read SEC document |
| September 15, 2021 Filed Sep 21, 2021 20:01 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock · Derivative | 2,801 | $27.37 Strike: $27.37 | $76,663.37 |
DisclosureSEC source: 0001069530-21-000047 · certent-form4.xml · derivative · entry 3 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,801 shares Expires 2021-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 21, 2021 20:01 UTC |
GUSSIN ROBERT ZDirector
|
Tax withholdingCommon Stock | 1,746 | $43.92 | $76,684.32 |
DisclosureSEC source: 0001069530-21-000047 · certent-form4.xml · nonDerivative · entry 2 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,964 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
| September 15, 2021 Filed Sep 21, 2021 20:01 UTC |
GUSSIN ROBERT ZDirector
|
Exercise / conversionCommon Stock | 2,801 | $27.37 | $76,663.37 |
DisclosureSEC source: 0001069530-21-000047 · certent-form4.xml · nonDerivative · entry 1 GUSSIN ROBERT Z · CIK 0001245263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Feb 3, 2022 22:13 UTC |
Schoen EricChief Financial Officer
|
GiftCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001069530-22-000009 · certent-form5.xml · nonDerivative · entry 1 Schoen Eric · CIK 0001532303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 F1 · price: Bona Fide Gift Read SEC document |
| July 20, 2021 Filed Jul 20, 2021 21:21 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 2,801 | $20.23 Strike: $20.23 | $56,664.23 |
DisclosureSEC source: 0001069530-21-000040 · certent-form4.xml · derivative · entry 3 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Disclosed balance after: 0 Underlying: Common Stock · 2,801 shares Expires 2021-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2021 Filed Jul 20, 2021 21:21 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock | 2,801 | $20.23 | $56,664.23 |
DisclosureSEC source: 0001069530-21-000040 · certent-form4.xml · nonDerivative · entry 1 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Disclosed balance after: 326,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction represents exercise of stock options for cash. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:01 UTC |
BARBIER REMIDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 56,030 | $53.55 Strike: $53.55 | $3,000,406.50 |
DisclosureSEC source: 0001069530-21-000031 · certent-form4.xml · derivative · entry 3 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,030 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:01 UTC |
BARBIER REMIDirector · President and CEO
|
Tax withholdingCommon Stock | 53,965 | $55.60 | $3,000,454.00 |
DisclosureSEC source: 0001069530-21-000031 · certent-form4.xml · nonDerivative · entry 2 BARBIER REMI · CIK 0001133806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,920 F1 · balance_after: Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.